Oak Associates LTD Amgen Inc Transaction History

Oak Associates LTD

  • $1.48 Billion
  • Q3 2024

A detailed history of Oak Associates LTD transactions in Amgen Inc stock. As of the latest transaction made, Oak Associates LTD holds 123,968 shares of AMGN stock, worth $34.1 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares
123,968
Previous 125,300 1.06%
Holding current value
$34.1 Million
Previous $39.1 Million 2.03%
% of portfolio
2.69%
Previous 2.6%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$309.38 - $337.38 $412,094 - $449,390
-1,332 Reduced 1.06%
123,968 $39.9 Million
Q2 2024

Aug 08, 2024
SELL
$262.75 - $319.31 $98,794 - $120,060
-376 Reduced 0.3%
125,300 $39.1 Million
Q1 2024

May 10, 2024
SELL
$268.87 - $324.56 $467,833 - $564,734
-1,740 Reduced 1.37%
125,676 $35.7 Million
Q4 2023

Feb 14, 2024
SELL
$255.7 - $288.46 $312,465 - $352,498
-1,222 Reduced 0.95%
127,416 $36.7 Million
Q3 2023

Nov 13, 2023
SELL
$218.65 - $271.46 $190,881 - $236,984
-873 Reduced 0.67%
128,638 $34.6 Million
Q2 2023

Aug 11, 2023
SELL
$214.27 - $253.37 $3.9 Million - $4.61 Million
-18,203 Reduced 12.32%
129,511 $28.8 Million
Q1 2023

May 11, 2023
SELL
$225.79 - $275.2 $60,963 - $74,304
-270 Reduced 0.18%
147,714 $35.7 Million
Q4 2022

Feb 09, 2023
SELL
$229.03 - $291.01 $1.32 Million - $1.68 Million
-5,777 Reduced 3.76%
147,984 $38.9 Million
Q3 2022

Nov 09, 2022
SELL
$224.46 - $253.15 $167,896 - $189,356
-748 Reduced 0.48%
153,761 $34.7 Million
Q2 2022

Aug 12, 2022
SELL
$230.71 - $256.74 $263,240 - $292,940
-1,141 Reduced 0.73%
154,509 $37.6 Million
Q1 2022

May 12, 2022
SELL
$219.27 - $242.57 $1.23 Million - $1.36 Million
-5,619 Reduced 3.48%
155,650 $37.6 Million
Q4 2021

Feb 10, 2022
SELL
$198.88 - $227.6 $443,502 - $507,548
-2,230 Reduced 1.36%
161,269 $36.3 Million
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $17,193 - $20,144
-81 Reduced 0.05%
163,499 $34.8 Million
Q2 2021

Aug 09, 2021
SELL
$233.58 - $259.14 $170,980 - $189,690
-732 Reduced 0.45%
163,580 $39.9 Million
Q1 2021

May 13, 2021
SELL
$221.91 - $258.6 $301,575 - $351,437
-1,359 Reduced 0.82%
164,312 $40.9 Million
Q4 2020

Feb 12, 2021
SELL
$216.38 - $257.67 $351,617 - $418,713
-1,625 Reduced 0.97%
165,671 $38.1 Million
Q3 2020

Nov 13, 2020
SELL
$234.65 - $260.95 $1.17 Million - $1.3 Million
-4,968 Reduced 2.88%
167,296 $42.5 Million
Q2 2020

Aug 11, 2020
SELL
$197.81 - $242.74 $932,080 - $1.14 Million
-4,712 Reduced 2.66%
172,264 $40.6 Million
Q1 2020

May 15, 2020
SELL
$182.24 - $241.7 $6.89 Million - $9.14 Million
-37,813 Reduced 17.6%
176,976 $35.9 Million
Q4 2019

Feb 13, 2020
SELL
$189.21 - $243.2 $1.45 Million - $1.86 Million
-7,646 Reduced 3.44%
214,789 $51.8 Million
Q3 2019

Nov 12, 2019
SELL
$174.11 - $208.62 $962,654 - $1.15 Million
-5,529 Reduced 2.43%
222,435 $43 Million
Q2 2019

Aug 09, 2019
BUY
$166.7 - $195.41 $1.47 Million - $1.73 Million
8,843 Added 4.04%
227,964 $42 Million
Q1 2019

May 09, 2019
SELL
$180.87 - $203.88 $1.31 Million - $1.48 Million
-7,240 Reduced 3.2%
219,121 $41.6 Million
Q4 2018

Feb 07, 2019
BUY
$178.4 - $208.25 $1.91 Million - $2.23 Million
10,703 Added 4.96%
226,361 $44.1 Million
Q3 2018

Nov 13, 2018
BUY
$185.29 - $208.89 $15,008 - $16,920
81 Added 0.04%
215,658 $44.7 Million
Q2 2018

Aug 14, 2018
SELL
$166.05 - $186.51 $11,125 - $12,496
-67 Reduced 0.03%
215,577 $39.8 Million
Q1 2018

May 14, 2018
SELL
$169.43 - $198.0 $2,710 - $3,168
-16 Reduced 0.01%
215,644 $36.8 Million
Q4 2017

Feb 08, 2018
SELL
$168.79 - $188.59 $17,891 - $19,990
-106 Reduced 0.05%
215,660 $37.5 Million
Q3 2017

Nov 07, 2017
SELL
$167.29 - $191.0 $12,379 - $14,134
-74 Reduced 0.03%
215,766 $40.2 Million
Q2 2017

Aug 18, 2017
BUY
N/A
215,840
215,840 $37.2 Million

Others Institutions Holding AMGN

# of Institutions
3,091
Shares Held
406M
Call Options Held
7.56M
Put Options Held
7.16M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $147B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Oak Associates LTD Portfolio

Follow Oak Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email